Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.040
-0.160 (-5.00%)
At close: Jul 16, 2026, 4:00 PM EDT
3.100
+0.060 (1.97%)
After-hours: Jul 16, 2026, 6:50 PM EDT
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $183.68 million as of July 16, 2026. Its market cap has increased by 7.92% in one year.
Market Cap
183.68M
Enterprise Value
46.59M
1-Year Change
7.92%
Ranking
Category
Stock Price
$3.04
ChartMarket Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $183.68M, a decrease of -59.77%. That is a compound annual growth rate of -8.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 183.68M | -15.94% |
| Dec 31, 2025 | 218.50M | -29.45% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 205.71M |
| Outlook Therapeutics | 199.42M |
| Codexis | 199.06M |
| Immunic | 198.06M |
| Humacyte | 192.23M |
| Minerva Neurosciences | 191.95M |
| Korro Bio | 187.85M |
| Protalix BioTherapeutics | 187.73M |